Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Ibrahim

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Hazardous Materials|September 15, 2019
Hydroxyapatite, a multifunctional material for air, water and soil pollution control: A reviewMaya Ibrahim, Madona Labaki, Jean-Marc Giraudon, et al.
Journal of Affective Disorders|December 15, 2024
Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental healthThomas D Meyer, Maya Ibrahim, Lauren N Vale, et al.
Journal of Affective Disorders|October 18, 2025
Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?Lauren N Vale, Maya Ibrahim, Leonardo Fávaro-Pereira, et al.
BMJ Open|July 13, 2026
Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility studyThomas D Meyer, Lauren N Vale, Maya Ibrahim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Hazardous Materials|September 15, 2019
Hydroxyapatite, a multifunctional material for air, water and soil pollution control: A reviewMaya Ibrahim, Madona Labaki, Jean-Marc Giraudon, et al.
Journal of Affective Disorders|December 15, 2024
Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental healthThomas D Meyer, Maya Ibrahim, Lauren N Vale, et al.
Journal of Affective Disorders|October 18, 2025
Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?Lauren N Vale, Maya Ibrahim, Leonardo Fávaro-Pereira, et al.
BMJ Open|July 13, 2026
Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility studyThomas D Meyer, Lauren N Vale, Maya Ibrahim, et al.
Pageof 1